All News

bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina

Ref: Business Wire

Tags: Press Release bluebird bio Corporate Affairs

Evox Therapeutics Awarded £1.5 Million in Funding From Innovate UK

Ref: PR Newswire

Tags: Press Release Evox Therapeutics Corporate Affairs

Moberg Pharma Completes Enrollment for MOB-015 Phase 3 Study in Europe

Ref: PR Newswire

Tags: Press Release Bayer Cipher Moberg Pharma Fungal Infections Clinical Research (R&D)MOB-015

EMA Management Board: highlights of March 2019 meeting

Ref: EMA

Tags: Press Release European Union EMA Paul-Ehrlich-Institut Regulatory Affairs

Physician Views Results - Dermatologists intrigued by Dermira’s lebrikizumab data…

Ref: Physician Views Desk

Tags: Physician Views Poll Results Dermira Regeneron Sanofi Dermatitis Clinical Research (R&D) Medical Affairs Dupixent lebrikizumab

Qiming Backs Abbisko in $42M Series B

Ref: Abbisko

Tags: Press Release Abbisko Liver Cancer Corporate Affairs ABSK011 ABSK021

WuXi AppTec Reports Strong 2018 Annual Results

Ref: PR Newswire

Tags: Press Release WuXi PharmaTech Corporate Affairs

SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update

Ref: GlobeNewswire

Tags: Press Release Sellas Corporate Affairs galinpepimut-S nelipepimut-S

Immutep Announces United States Patent Grant for Eftilagimod Alpha in Cancer

Ref: GlobeNewswire

Tags: Press Release Immutep Breast Cancer Corporate Affairs ImmuFact IMP321

Eisai to Present Latest Research about Alzheimer's Disease/Dementia Pipeline at The 14th International Conference on Alzheimer's & Parkinson's Diseases

Ref: PR Newswire

Tags: Press Release BioArctic Neuroscience Biogen Eisai Dementia Clinical Research (R&D) Medical Affairs ADPD BAN2401 elenbecestat E2027